Oryzon Genomics SA
MAD:ORY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oryzon Genomics SA
MAD:ORY
|
ES |
|
DBS Group Holdings Ltd
SGX:D05
|
SG |
Multiples-Based Value
The Multiples-Based Value for
Oryzon Genomics SA (ORY) under the Base Case is 2.45 EUR.
Compared with the current market price of 3.12 EUR, the stock appears
Overvalued by 21% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.